Pfizer Recalls Another Blood Pressure Medication

April 25, 2022

The pharmaceutical firm Pfizer has voluntary recalled a blood stress treatment for the second time in a month.

Pfizer is recalling 5 plenty of blood stress drugs Accupril due to elevated ranges of a nitrosamine, Nnitroso-quinapril, the corporate mentioned in a information launch posted Friday on the FDA web site.

Nitrosamines are present in water and meals, together with grilled meats and dairy merchandise, however impurities might enhance an individual’s most cancers threat over lengthy durations of time, Pfizer mentioned.

Accupril is used to decrease blood stress and handle coronary heart failure. Pfizer mentioned it has not acquired any experiences of opposed reactions by individuals taking the drug.

“Pfizer believes the benefit/risk profile of the products remains positive based on currently available data. Although long-term ingestion of Nnitroso-quinapril may be associated with a potential increased cancer risk in humans, there is no immediate risk to patients taking this medication,” the corporate mentioned.

The Accupril tables are bought in 10-, 20- and 40-mg doses. The affected lot numbers are DR9639, DX8682, DG1188, DX6031, and CK6260.

Patients taking the product ought to speak to their physician. Patients with the affected product ought to name 888-345-0481.

Pfizer recalled one other blood stress treatment on March 22.

The affected merchandise in that recall are quinapril HCl/hydrochlorothiazide (Accuretic) tablets that Pfizer distributes, and two licensed generics, quinapril plus hydrochlorothiazide and quinapril HCl/hydrochlorothiazide, distributed by Greenstone. The recall is over greater than accepted ranges of N-nitroso-quinapril, a compound referred to as a nitrosamine.